Nanopore Sequencing for RNA Vaccines and Therapeutics: Advancing Drug Development and Quality Control

Advancements in sequencing technologies are reshaping biopharmaceutical development, with nanopore sequencing emerging as a powerful tool for real-time genetic analysis. While traditionally seen as a niche solution, its unique ability to offer real-time, scalable and portable sequencing has made it a game changer in various fields.

This session will explore how nanopore sequencing is evolving beyond its established applications, including its future role in RNA analysis and its growing adoption in good manufacturing practice (GMP) environments. In this webinar, the expert speakers will discuss how Oxford Nanopore Technologies can complement and enhance traditional analytical methods, offering new opportunities in process development and quality control.

Register for the webinar to gain insights into how nanopore sequencing is poised to become a key player in the biopharma industry and how it can be leveraged in drug development and manufacturing.

Keywords: Quality Control, Drug Development, GMP, Clinical Research, Biopharma, Biotech, CRO, Clinical Data, Regulatory, mRNA Vaccines, Cell & Gene Therapies, CDMO/CMO, Quality, CGT

Others Details

Life Sciences,Pharma,Biotech,Drug Discovery & Development,Cell and Gene Therapy,Pharma Manufacturing & Supply Chain